Oncologic Drugs Advisory Committee Discussion on FDA Requirements or Approval of New Drugs for Treatment of Colon and Rectal Cancer
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 2, 1998
April 1, 2019
4902e903-ac24-437e-a3f6-69c616094804
Related Documents
Format and Content of the Human Pharmacokinetics and Bioavailability Section of an Application
Guidance DocumentFebruary 1, 1987Center for Drug Evaluation and Research
FDA Requirements for Approval of Drugs to Treat Non-Small Cell Lung Cancer
Guidance DocumentMarch 2, 1998Center for Drug Evaluation and Research
Preparation of Investigational New Drug Products (Human and Animal): Guidance for Industry
Guidance DocumentNovember 1, 1992Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.